Cargando…
Erythropoietin in the critically ill: do we ask the right questions?
There is a plethora of experimental data on the potential therapeutic benefits of recombinant human erythropoietin (rhEPO) and its synthetic derivatives in critical care medicine, in particular in ischemia/reperfusion injury. Most of the recent clinical trials have not shown clear benefits, and, in...
Autores principales: | McCook, Oscar, Georgieff, Michael, Scheuerle, Angelika, Möller, Peter, Thiemermann, Christoph, Radermacher, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3682241/ https://www.ncbi.nlm.nih.gov/pubmed/23016869 http://dx.doi.org/10.1186/cc11430 |
Ejemplares similares
-
Deworming and Development: Asking the Right Questions, Asking the Questions Right
por: Bundy, Donald A. P., et al.
Publicado: (2009) -
Comparison of carbamylated versus recombinant erythropoietin during spinal cord ischemia/reperfusion injury
por: Simon, F, et al.
Publicado: (2010) -
Autoimmunity: Are we asking the right question?
por: Matzinger, Polly
Publicado: (2022) -
Telehealth Regulatory and Legal Considerations: Frequently Asked Questions
por: Cason, Jana, et al.
Publicado: (2011) -
Burnout in Medicine: Are We Asking the Right Questions?
por: DePorre, Alexandra, et al.
Publicado: (2023)